This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shi, E
Right arrow Articles by McKeehan, W L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, E
Right arrow Articles by McKeehan, W L

 Previous Article  |  Next Article 

Mol Cell Biol. 1993 July; 13(7): 3907-3918

Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants.

E Shi, M Kan, J Xu, F Wang, J Hou and W L McKeehan

W. Alton Jones Cell Science Center, Inc., Lake Placid, New York 12946.

ABSTRACT

A differentiated liver cell (HepG2), which exhibits a dose-dependent growth-stimulatory and growth-inhibitory response to heparin-binding fibroblast growth factor type 1 (FGF-1), displays high- and low-affinity receptor phenotypes and expresses specific combinatorial splice variants alpha 1, beta 1, and alpha 2 of the FGF receptor (FGF-R) gene (flg). The extracellular domains of the alpha and beta variants consist of three and two immunoglobulin loops, respectively, while the intracellular variants consist of a tyrosine kinase (type 1) isoform and a kinase-defective (type 2) isoform. The type 2 isoform is also devoid of the two major intracellular tyrosine autophosphorylation sites (Tyr-653 and Tyr-766) in the type 1 kinase. An analysis of ligand affinity, dimerization, autophosphorylation, and interaction with src homology region 2 (SH2) substrates of the recombinant alpha 1, beta 1, and alpha 2 isoforms was carried out to determine whether dimerization of the combinatorial splice variants might explain the dose-dependent opposite mitogenic effects of FGF. Scatchard analysis indicated that the alpha and beta isoforms exhibit low and high affinity for ligand, respectively. The three combinatorial splice variants dimerized in all combinations. FGF enhanced dimerization and kinase activity, as assessed by receptor autophosphorylation. Phosphopeptide analysis revealed that phosphorylation of Tyr-653 was reduced relative to phosphorylation of Tyr-766 in the type 1 kinase component of heterodimers of the type 1 and type 2 isoforms. The SH2 domain substrate, phospholipase C gamma 1 (PLC gamma 1), associated with the phosphorylated type 1-type 2 heterodimers but was phosphorylated only in preparations containing the type 1 kinase homodimer. The results suggest that phosphorylation of Tyr-653 within the kinase catalytic domain, but not Tyr-766 in the COOH-terminal domain, may be stringently dependent on a trans intermolecular mechanism within FGF-R kinase homodimers. Although phosphotyrosine 766 is sufficient for interaction of PLC gamma 1 and other SH2 substrates with the FGF-R kinase, phosphorylation and presumably activation of substrates require the kinase homodimer and phosphorylation of Tyr-653. We propose that complexes of phosphotyrosine 766 kinase monomers and SH2 domain signal transducers may constitute unactivated presignal complexes whose active or inactive fate depends on homodimerization with a kinase or heterodimerization with a kinase-defective monomer, respectively. The results suggest a mechanism for control of signal transduction by different concentrations of ligand through heterodimerization of combinatorial splice variants from the same receptor gene.


Mol Cell Biol. 1993 July; 13(7): 3907-3918




This article has been cited by other articles:

  • Cotton, L. M., O'Bryan, M. K., Hinton, B. T. (2008). Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction. Endocr. Rev. 29: 193-216 [Abstract] [Full Text]  
  • Zhang, Y., McKeehan, K., Lin, Y., Zhang, J., Wang, F. (2008). Fibroblast Growth Factor Receptor 1 (FGFR1) Tyrosine Phosphorylation Regulates Binding of FGFR Substrate 2{alpha} (FRS2{alpha}) But Not FRS2 to the Receptor. Mol. Endocrinol. 22: 167-175 [Abstract] [Full Text]  
  • French, P. J., Peeters, J., Horsman, S., Duijm, E., Siccama, I., van den Bent, M. J., Luider, T. M., Kros, J. M., van der Spek, P., Sillevis Smitt, P. A. (2007). Identification of Differentially Regulated Splice Variants and Novel Exons in Glial Brain Tumors Using Exon Expression Arrays. Cancer Res. 67: 5635-5642 [Abstract] [Full Text]  
  • Kirby, J. L., Yang, L., Labus, J. C., Hinton, B. T. (2003). Characterization of Fibroblast Growth Factor Receptors Expressed in Principal Cells in the Initial Segment of the Rat Epididymis. Biol. Reprod. 68: 2314-2321 [Abstract] [Full Text]  
  • Duplan, S. M., Theoret, Y., Kenigsberg, R. (2002). Antitumor Activity of Fibroblast Growth Factors (FGFs) for Medulloblastoma May Correlate with FGF Receptor Expression and Tumor Variant. Clin. Cancer Res. 8: 246-257 [Abstract] [Full Text]  
  • Jin, W., Huang, E. S.-C., Bi, W., Cote, G. J. (1999). Redundant Intronic Repressors Function to Inhibit Fibroblast Growth Factor Receptor-1 alpha -Exon Recognition in Glioblastoma Cells. J. Biol. Chem. 274: 28035-28041 [Abstract] [Full Text]  
  • Bian, H., Reed, E. F. (1999). Alloantibody-Mediated Class I Signal Transduction in Endothelial Cells and Smooth Muscle Cells: Enhancement by IFN-{gamma} and TNF-{alpha}. J. Immunol. 163: 1010-1018 [Abstract] [Full Text]  
  • Sheikh, F., Fandrich, R. R., Kardami, E., Cattini, P. A. (1999). Overexpression of long or short FGFR-1 results in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures. Cardiovasc Res 42: 696-705 [Abstract] [Full Text]  
  • Byrd, V. M., Ballard, D. W., Miller, G. G., Thomas, J. W. (1999). Fibroblast Growth Factor-1 (FGF-1) Enhances IL-2 Production and Nuclear Translocation of NF-{kappa}B in FGF Receptor-Bearing Jurkat T Cells. J. Immunol. 162: 5853-5859 [Abstract] [Full Text]  
  • Jin, W., Bi, W., Huang, E. S-C., Cote, G. J. (1999). Glioblastoma Cell-specific Expression of Fibroblast Growth Factor Receptor-1{beta} Requires an Intronic Repressor of RNA Splicing. Cancer Res. 59: 316-319 [Abstract] [Full Text]  
  • McEwen, D. G., Ornitz, D. M. (1998). Regulation of the Fibroblast Growth Factor Receptor 3 Promoter and Intron I Enhancer by Sp1 Family Transcription Factors. J. Biol. Chem. 273: 5349-5357 [Abstract] [Full Text]  
  • Lovicu, F., Overbeek, P. (1998). Overlapping effects of different members of the FGF family on lens fiber differentiation in transgenic mice. Development 125: 3365-3377 [Abstract]  
  • Cote, G. J., Huang, E. S-C., Jin, W., Morrison, R. S. (1997). Sequence Requirements for Regulated RNA Splicing of the Human Fibroblast Growth Factor Receptor-1 alpha Exon. J. Biol. Chem. 272: 1054-1060 [Abstract] [Full Text]  
  • Tanahashi, T., Suzuki, M., Imamura, T., Mitsui, Y. (1996). Identification of a 79-kDa Heparin-binding Fibroblast Growth Factor (FGF) Receptor in Rat Hepatocytes and Its Correlation with the Different Growth Responses to FGF-1 between Hepatocyte Subpopulations. J. Biol. Chem. 271: 8221-8227 [Abstract] [Full Text]  
  • Ault, K., Durmowicz, G, Galione, A, Harger, P., Busa, W. (1996). Modulation of Xenopus embryo mesoderm-specific gene expression and dorsoanterior patterning by receptors that activate the phosphatidylinositol cycle signal transduction pathway. Development 122: 2033-2041 [Abstract]  
  • Patrie, K. M., Kudla, A. J., Olwin, B. B., Chiu, I.-M. (1995). Conservation of Ligand Specificity between the Mammalian and Amphibian Fibroblast Growth Factor Receptors. J. Biol. Chem. 270: 29018-29024 [Abstract] [Full Text]  
  • Richard, C., Liuzzo, J. P., Moscatelli, D. (1995). Fibroblast Growth Factor-2 Can Mediate Cell Attachment by Linking Receptors and Heparan Sulfate Proteoglycans on Neighboring Cells. J. Biol. Chem. 270: 24188-24196 [Abstract] [Full Text]  
  • Gillespie, L. L., Chen, G., Paterno, G. D. (1995). Cloning of a Fibroblast Growth Factor Receptor 1 Splice Variant from Xenopus Embryos That Lacks a Protein Kinase C Site Important for the Regulation of Receptor Activity. J. Biol. Chem. 270: 22758-22763 [Abstract] [Full Text]  
  • Zhu, H., Ramnarayan, K., Anchin, J., Miao, W. Y., Sereno, A., Millman, L., Zheng, J., Balaji, V. N., Wolff, M. E. (1995). Glu-96 of Basic Fibroblast Growth Factor Is Essential for High Affinity Receptor Binding. J. Biol. Chem. 270: 21869-21874 [Abstract] [Full Text]  
  • Wang, F., Kan, M., Xu, J., Yan, G., McKeehan, W. L. (1995). Ligand-specific Structural Domains in the Fibroblast Growth Factor Receptor. J. Biol. Chem. 270: 10222-10230 [Abstract] [Full Text]  
  • Mathieu, M., Kiefer, P., Mason, I., Dickson, C. (1995). Fibroblast Growth Factor (FGF) 3 from Xenopus laevis (XFGF3) Binds with High Affinity to FGF Receptor 2. J. Biol. Chem. 270: 6779-6787 [Abstract] [Full Text]  
  • Xu, J., McKeehan, K., Matsuzaki, K., McKeehan, W. L. (1995). Inhibin Antagonizes Inhibition of Liver Cell Growth by Activin by a Dominant-negative Mechanism. J. Biol. Chem. 270: 6308-6313 [Abstract] [Full Text]  
  • Robinson, M., MacMillan-Crow, L., Thompson, J., Overbeek, P. (1995). Expression of a truncated FGF receptor results in defective lens development in transgenic mice. Development 121: 3959-3967 [Abstract]  
  • MacArthur, C., Lawshe, A, Xu, J, Santos-Ocampo, S, Heikinheimo, M, Chellaiah, A., Ornitz, D. (1995). FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development. Development 121: 3603-3613 [Abstract]  
  • Nurcombe, V., Smart, C. E., Chipperfield, H., Cool, S. M., Boilly, B., Hondermarck, H. (2000). The Proliferative and Migratory Activities of Breast Cancer Cells Can Be Differentially Regulated by Heparan Sulfates. J. Biol. Chem. 275: 30009-30018 [Abstract] [Full Text]  
  • Lee, S. H., Schloss, D. J., Swain, J. L. (2000). Maintenance of Vascular Integrity in the Embryo Requires Signaling through the Fibroblast Growth Factor Receptor. J. Biol. Chem. 275: 33679-33687 [Abstract] [Full Text]